# Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

> **NCT03117036** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 600 (estimated)

## Conditions studied

- Lymphoma, Non-Hodgkin
- Lymphoma, Hodgkin

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03117036
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-03-01
- **Primary completion:** 2026-12-28
- **Final completion:** 2026-12-28
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117036, "Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03117036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*